Skip to main content

Table 2 Variation of the sample size according to the difference of the outcome of interest

From: Comparison of intermittent screening (using ultra-sensitive malaria rapid diagnostic test) and treatment (using a newly registered antimalarial pyronaridine-artesunate—PYRAMAX®) to standard intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria in pregnant women living in endemic areas: ULTRAPYRAPREG

 

IPTp

IST

Sample size

Low birth weight

10.5

15.7

122

Malaria infection

18.9

23.4

196

Anemia

30

25

220